Biotech

Third Wave Technologies has applied for Food and Drug Administration approval of a new molecular test to detect Cystic Fibrosis, a hereditary disease that affects 30,000 Americans. The company filed a 510(k), a type of application that helps companies get their products on the U.S....

Pharma stocks had a mixed performance in 2006, and merger and acquisition activity was the name of the game for the likes of Abbott Labs, 3M, and Monsanto, according to columnist Michael Rosen. In this edition of Yer Biotech Blues, he predicts the M&A trend...

University of Wisconsin-Madison professor David Beebe is the recipient of the first ever Pioneer of Miniaturization Prize. The award will be presented by the Lab on a Chip Journal and by Corning, Inc. during the 10th annual International Conference on Miniaturized Systems for Chemistry and...

Tata Memorial Centre, and advanced center for cancer treatment and research, will be the first hospital in India to install TomoTherapy's Hi-Art radiotherapy equipment as part of a new partnership between TomoTherapy and Kirloskar Theratronics, Ltd. ...

Contrary to popular belief, the University of Wisconsin's flagship campus isn't just for Madison, and a new entrepreneurship program made possible by the Ewing Marion Kauffman Foundation promises to spread the wealth around the entire state - literally. Inside Wisconsin columnist Tom Still believes this...

CellCura, a Norwegian biotechnology company, has opened an office in Madison to facilitate collaboration with scientists at the WiCell Research Institute, and that has visions of a stem cell invasion dancing in the heads of Wisconisn biotechnology officials. CellCura will open in Madison's University Research...

Inside Wisconsin columnist Tom Still recommends a little “back to the future” as he explains the many ways Wisconsin can use its technological expertise to launch a proposed space camp on the moon. Whether America will book a return trip to its only satellite remains...

Researchers at the University of Wisconsin-Madison have demonstrated in mice that neural stem cells have the ability to mimic the blood-brain barrier, which acts as a gatekeeper for the brain. The next step will be to produce similar results using human cells, which could lead...